Reshaping the dynamic tumor immune microenvironment of liver cancer: From treatment-induced evolution to Novel combined strategies
Xueyachun  Wang Ning  Shanghongye(corresponding author)

The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine/National acupuncture and moxibustion Clinical Medical Research Center of Traditional Chinese Medicine, Tianjin, 300381;

Beichen District Hospital of Traditional Chinese Medicine Tianjin，Tianjin，300400；

Abstract: In the treatment of liver cancer, the remodeling of the tumor immune microenvironment is of great significance. The research focuses on the evolution of the dynamic tumor immune microenvironment of liver cancer induced by treatment, and analyzes the influence of different treatment methods on its cell composition, cytokines and other aspects. Based on this evolution feature, exploring new combined strategies to enhance the anti-tumor immune effect and overcome immune escape can provide new ideas for the treatment of liver cancer and is expected to improve the prognosis of patients.

Key words: Liver cancer Dynamic tumor immune microenvironment Treatment-induced evolution; New joint strategy

References

[1]Yang Zhihui, Miao Jingxiaguang, Liao Rongrong. Key words of tumor immunotherapy nursing related research: Open visualization analysis [J]. Journal of Nursing, 2023,30 (1) : 12-16.

[2] Yang He, Zhang Sheng, Xin Yanfei. Research Progress of Tumor Immunotherapy [J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2016,21 (9) : 1074-1080.

[3] Zhang Sihan (Review) Xu Bin (Proofreading). The Current Development Status and Prospect of Tumor Immunotherapy Drugs [J]. International Journal of Pathology and Clinical Practice, 2021, 41(10):2447-2460.

[4] Li Youbing, Jiang Jiaji. New Advances in Systemic Therapy for Primary Liver Cancer [J] Liver,2021,26(4):349-352.

[5] Liu Lin, Qin Shukui. Research Status and Progress of Molecular Targeted Drugs and immune checkpoint Inhibitors in the treatment of advanced hepatocellular carcinoma [J]. Journal of Clinical Oncology,2019,24(9):839-849.